About Accutar Biotechnology
Accutar Biotechnology is a company based in Brooklyn (United States) founded in 2015 by Jie Fan.. Accutar Biotechnology has raised $91.45 million across 5 funding rounds from investors including Primavera Capital Group, YITU and Yunfeng Capital. Accutar Biotechnology offers products and services including ChemiRise, Orbital, Virtual Screen, Intelligent-SAR, and Chemi-Net. Accutar Biotechnology operates in a competitive market with competitors including Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others.
- Headquarter Brooklyn, United States
- Founders Jie Fan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Accutar Biotechnology Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$91.45 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
Primavera Capital Group
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accutar Biotechnology
Accutar Biotechnology offers a comprehensive portfolio of products and services, including ChemiRise, Orbital, Virtual Screen, Intelligent-SAR, and Chemi-Net. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for accelerating chemical compound discovery.
Virtual screening platform for drug candidate identification.
System for intelligent drug design and analysis.
Tool for structure-activity relationship predictions.
Network for chemical data modeling and predictions.
Unlock access to complete
Unlock access to complete
Funding Insights of Accutar Biotechnology
Accutar Biotechnology has successfully raised a total of $91.45M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(06 Dec 2017)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Series C - Accutar Biotechnology | Valuation | Yunfeng Capital , Coatue |
|
| Jan, 2021 | Amount | Series C - Accutar Biotechnology | Valuation |
investors |
|
| Sep, 2020 | Amount | Series B - Accutar Biotechnology | Valuation | Primavera , CDH |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Accutar Biotechnology
Accutar Biotechnology has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Primavera Capital Group, YITU and Yunfeng Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed by Yunfeng Capital in China.
|
Founded Year | Domain | Location | |
|
Provider of an investment platform for various stages
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Accutar Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Accutar Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Accutar Biotechnology Comparisons
Competitors of Accutar Biotechnology
Accutar Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
An agentic AI platform is developed for biomedical research insights.
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
AI platform used for extracting antibody data from scientific papers.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| domain | founded_year | HQ Location |
AI-driven drug discovery platform for the treatment of cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Accutar Biotechnology
Frequently Asked Questions about Accutar Biotechnology
When was Accutar Biotechnology founded?
Accutar Biotechnology was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Accutar Biotechnology located?
Accutar Biotechnology is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Who is the current CEO of Accutar Biotechnology?
Jie Fan is the current CEO of Accutar Biotechnology. They have also founded this company.
Is Accutar Biotechnology a funded company?
Accutar Biotechnology is a funded company, having raised a total of $91.45M across 5 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Dec 06, 2017.
What does Accutar Biotechnology do?
Accutar Biotechnology was founded in 2015 and is based in Brooklyn, United States. Operations focus on computation-aided drug discovery within the biotechnology sector. An AI-assisted tool has been developed for predicting drug pocket side-chain conformations and performing drug docking, with accuracy exceeding standard methods. Chemical compound properties, such as solubility and binding affinity, are also predicted. Platforms include Orbital Docking and One-click Docking for these functions.
Who are the top competitors of Accutar Biotechnology?
Accutar Biotechnology's top competitors include Owkin, Formation Bio and XtalPi.
What products or services does Accutar Biotechnology offer?
Accutar Biotechnology offers ChemiRise, Orbital, Virtual Screen, Intelligent-SAR, and Chemi-Net.
Who are Accutar Biotechnology's investors?
Accutar Biotechnology has 8 investors. Key investors include Primavera Capital Group, YITU, Yunfeng Capital, Coatue, and 3W Partners.